These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 16570701)

  • 21. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.
    Lozniewski A; Lion C; Mory F; Weber M
    Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of quinupristin/dalfopristin against gram-positive bacteria Haemophilus influenzae and Branhamella catarrhalis in Taiwan.
    Wang FD; Lin ML; Liu CY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jun; 63(6):433-9. PubMed ID: 10925532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E; Dalhoff A; Korfmann G
    Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method.
    Abb J
    Diagn Microbiol Infect Dis; 2002 Aug; 43(4):319-21. PubMed ID: 12151194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model: an additive effect of the combination.
    Firsov AA; Vostrov SN; Lubenko IY; Portnoy YA; Zinner SH
    Int J Antimicrob Agents; 2004 May; 23(5):451-6. PubMed ID: 15120722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Susceptibility to selected chemotherapeutics of Staphylococcus aureus strains resistant to methycyline isolated from clinical materials in the years 1991-1992 and 1997].
    Kochman M; Fordymacki P; Lawrynowicz-Paciorek M; Kałuzewski S; Mészáros J; Połowniak-Pracka H; Ochman E; Sztandar-Sztanderska M
    Med Dosw Mikrobiol; 1999; 51(3-4):187-98. PubMed ID: 10803247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains.
    Jones ME; Visser MR; Klootwijk M; Heisig P; Verhoef J; Schmitz FJ
    Antimicrob Agents Chemother; 1999 Feb; 43(2):421-3. PubMed ID: 9925551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combining quinupristin/dalfopristin with other agents for resistant infections.
    Brown J; Freeman BB
    Ann Pharmacother; 2004 Apr; 38(4):677-85. PubMed ID: 14990776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular fingerprinting of fusidic acid- and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
    Norazah A; Lim VKE; Koh YT; Rohani MY; Zuridah H; Spencer K; Ng PP; Kamel AGM
    J Med Microbiol; 2002 Dec; 51(12):1113-1116. PubMed ID: 12466411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. III. Novel, inducible resistance to macrolide-lincosamide-streptogramin B (MLS) antibiotics.
    Inouye Y; Morifuji K; Masumi N; Sugiyama M; Takesue Y; Kodama T; Yokoyama T
    Hiroshima J Med Sci; 1993 Sep; 42(3):101-7. PubMed ID: 8253604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of quinupristin/dalfopristin and other antibiotics against ampicillin-resistant enterococcus faecium.
    Wang FD; Liu IM; Liu CY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):119-23. PubMed ID: 10677922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility comparisons of normal preoperative conjunctival bacteria to fluoroquinolones.
    Hori Y; Nakazawa T; Maeda N; Sakamoto M; Yokokura S; Kubota A; Inoue T; Nishida K; Tano Y
    J Cataract Refract Surg; 2009 Mar; 35(3):475-9. PubMed ID: 19251140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro sensitivity of methicillin-resistant Staphylococcus aureus to fusidic acid and trimethoprim-sulfamethoxazole].
    Memikoğlu KO; Bayar B; Kurt O; Cokça F
    Mikrobiyol Bul; 2002 Apr; 36(2):141-5. PubMed ID: 12652865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative in vitro activity of penicillin G, levofloxacin, moxifloxacin, telithromycin, pristinamycin, quinupristin-dalfopristin and linezolid against ofloxacin-intermediate and -resistant Streptococcus pneumoniae.
    Frédénucci I; Chomarat M; Bercion R; Carricajo A; Celard M; Croizé J; Delubac F; Fèvre D; Fuhrmann C; Helfre M; Letouzey MN; Lelièvre H; Mandjee A; Marthelet P; Meley R; Perrier-Gros-Claude JD; Ros A; Roure C; Smati S; Thierry J; Tous J
    Clin Microbiol Infect; 2002 Oct; 8(10):680-3. PubMed ID: 12390289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus.
    Metzler K; Hansen GM; Hedlin P; Harding E; Drlica K; Blondeau JM
    Int J Antimicrob Agents; 2004 Aug; 24(2):161-7. PubMed ID: 15288315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes.
    Van de Velde S; Nguyen HA; Van Bambeke F; Tulkens PM; Grellet J; Dubois V; Quentin C; Saux MC
    J Antimicrob Chemother; 2008 Sep; 62(3):518-21. PubMed ID: 18544595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Susceptibility of Staphylococcus aureus isolated from blood to 11 antimicrobial agents and a review of the literature].
    Viudes A; Pérez-Bellés C; Tallón P; Cano J; Peñalver MC; Pemán J; Gobernado G
    Rev Esp Quimioter; 2002 Jun; 15(2):158-68. PubMed ID: 12582445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L; Nicola L; De Vecchi E
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Methicillin-resistant Staphylococcus aureus (MRSA) with high resistance to mupirocin in hospitals of the Gdańsk region].
    Wiśniewska K; Dajnowska-Stanczewa A; Galiński J; Garbacz K
    Med Dosw Mikrobiol; 2002; 54(4):285-92. PubMed ID: 12650051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on the resistance of methicillin-resistant staphylococcus aureus to iodophor and chlorhexidine].
    Zhang YH; Liu XY; Zhu LL; Yu YZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Mar; 25(3):248-50. PubMed ID: 15200941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.